The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines
Pedro Morais(ProQR Therapeutics (Netherlands)), Yi‐Tao Yu(University of Rochester Medical Center)
Cited by 264
Related Papers
Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors.
|Genes & Development|1992|488
Targeted pseudouridylation: An approach for suppressing nonsense mutations in disease genes
|Molecular Cell|2023|67
Translational and clinical development of therapeutic siRNA and ASOs: current industry practices, perspectives, and recommendations
|Nucleic Acids Research|2025|12